000277278 001__ 277278
000277278 005__ 20240229162343.0
000277278 0247_ $$2doi$$a10.1002/ejhf.2951
000277278 0247_ $$2pmid$$apmid:37369985
000277278 0247_ $$2ISSN$$a1388-9842
000277278 0247_ $$2ISSN$$a1879-0844
000277278 037__ $$aDKFZ-2023-01312
000277278 041__ $$aEnglish
000277278 082__ $$a610
000277278 1001_ $$00000-0002-4406-8555$$aAnker, Markus S$$b0
000277278 245__ $$aCardiovascular health-related quality of life in cancer: a prospective study comparing the ESC HeartQoL and EORTC QLQ-C30 questionnaire.
000277278 260__ $$aOxford$$bWiley$$c2023
000277278 3367_ $$2DRIVER$$aarticle
000277278 3367_ $$2DataCite$$aOutput Types/Journal article
000277278 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1698070644_11322
000277278 3367_ $$2BibTeX$$aARTICLE
000277278 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000277278 3367_ $$00$$2EndNote$$aJournal Article
000277278 500__ $$a2023 Sep;25(9):1635-1647
000277278 520__ $$aHealth-related quality of life (HRQoL) is highly relevant in cancer and often assessed with the EORTC QLQ-C30. Cardiovascular HRQoL in cancer can be measured with the ESC HeartQoL questionnaire. We compared these instruments and examined their prognostic value.Summary scores for EORTC QLQ-C30 (0-100 points) and HeartQoL (0-3 points) questionnaires were prospectively assessed in 290 patients with mostly advanced cancer (stage 3/4: 81%, 1-year mortality: 36%) and 50 healthy controls (similar age and sex). Additionally, physical function and activity assessments were performed.Both questionnaires demonstrated reduced HRQoL in patients with cancer vs controls (EORTC QLQ-C30: 67±20 vs 91±11, p<0.001; ESC HeartQoL: 1.8±0.8 vs 2.7±0.4, p<0.001). The instruments were strongly correlated with each other (summary scores (r=0.76), physical (r=0.81), and emotional subscales (r=0.75, all p<0.001)) and independently associated with all-cause mortality (best cut-offs: EORTC QLQ-C30 <82.69: hazard ratio (HR) 2.33, p=0.004, HeartQoL <1.50: HR 1.85, p=0.004 - adjusted for sex, age, left ventricular ejection fraction, NT-proBNP, hsTroponinT, cancer stage/type), with no differences in the strength of the association by sex (p-interaction>0.9). Combining both questionnaires identified three risk groups with highest mortality in patients below both cut-offs (vs. patients above both cut-offs: HR 3.60, p<0.001). Patients with results below both cut-offs, showed higher NT-proBNP and reduced physical function and activity.EORTC QLQ-C30 and ESC HeartQoL - assessing cancer and cardiovascular HRQoL - are both associated with increased mortality in cancer patients, with even greater stratification by combing both. Reduced HRQoL scores were associated with elevated cardiovascular biomarkers and decreased functional status. This article is protected by copyright. All rights reserved.
000277278 536__ $$0G:(DE-HGF)POF4-899$$a899 - ohne Topic (POF4-899)$$cPOF4-899$$fPOF IV$$x0
000277278 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000277278 650_7 $$2Other$$aEORTC QLQ-C30
000277278 650_7 $$2Other$$aHeartQoL
000277278 650_7 $$2Other$$apatients with cancer
000277278 650_7 $$2Other$$aquality of life
000277278 7001_ $$aPotthoff, Sophia K$$b1
000277278 7001_ $$aLena, Alessia$$b2
000277278 7001_ $$aPorthun, Jan$$b3
000277278 7001_ $$aHadzibegovic, Sara$$b4
000277278 7001_ $$aEvertz, Ruben$$b5
000277278 7001_ $$aDenecke, Corinna$$b6
000277278 7001_ $$aFröhlich, Ann-Kathrin$$b7
000277278 7001_ $$aSonntag, Frederike$$b8
000277278 7001_ $$aRegitz-Zagrosek, Vera$$b9
000277278 7001_ $$aRosen, Stuart D$$b10
000277278 7001_ $$aLyon, Alexander R$$b11
000277278 7001_ $$aLüscher, Thomas F$$b12
000277278 7001_ $$aSpertus, John A$$b13
000277278 7001_ $$aAnker, Stefan D$$b14
000277278 7001_ $$aKarakas, Mahir$$b15
000277278 7001_ $$0P:(DE-HGF)0$$aBullinger, Lars$$b16
000277278 7001_ $$0P:(DE-HGF)0$$aKeller, Ulrich$$b17
000277278 7001_ $$aLandmesser, Ulf$$b18
000277278 7001_ $$aButler, Javed$$b19
000277278 7001_ $$avon Haehling, Stephan$$b20
000277278 773__ $$0PERI:(DE-600)1500332-2$$a10.1002/ejhf.2951$$gp. ejhf.2951$$n9$$p1635-1647$$tEuropean journal of heart failure$$v25$$x1388-9842$$y2023
000277278 909CO $$ooai:inrepo02.dkfz.de:277278$$pVDB
000277278 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b16$$kDKFZ
000277278 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b17$$kDKFZ
000277278 9131_ $$0G:(DE-HGF)POF4-899$$1G:(DE-HGF)POF4-890$$2G:(DE-HGF)POF4-800$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000277278 9141_ $$y2023
000277278 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2022-11-08$$wger
000277278 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2022-11-08
000277278 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2022-11-08
000277278 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2023-10-21$$wger
000277278 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bEUR J HEART FAIL : 2022$$d2023-10-21
000277278 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-21
000277278 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-21
000277278 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-21
000277278 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-21
000277278 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-21
000277278 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-21
000277278 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-21
000277278 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-10-21
000277278 915__ $$0StatID:(DE-HGF)9915$$2StatID$$aIF >= 15$$bEUR J HEART FAIL : 2022$$d2023-10-21
000277278 9201_ $$0I:(DE-He78)BE01-20160331$$kBE01$$lDKTK Koordinierungsstelle Berlin$$x0
000277278 980__ $$ajournal
000277278 980__ $$aVDB
000277278 980__ $$aI:(DE-He78)BE01-20160331
000277278 980__ $$aUNRESTRICTED